The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global urinary incontinence devices market size reached US$ 2.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2027, exhibiting a growth rate (CAGR) of 10.77% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Urinary incontinence is a medical condition that leads to the involuntary loss of urine. It is treated using medical devices, which help build and strengthen pelvic floor muscles and treat chronic urinary incontinence. These devices include electrical muscle stimulation that assists in the effective, safe, and non-invasive treatment of stress, urge, and mixed urinary incontinence. Presently, several manufacturers are developing purpose-based devices for the female population. They are introducing a wide range of small, tampon-like disposable devices for everyday activities and flexible silicone rings to prevent urine leakage and support the urethra in women with vaginal prolapse.
Neurological diseases, diabetes and obesity, along with the consumption of foods like caffeine, sweeteners, chocolates, carbonated drinks, sparkling water, artificial chili peppers, and muscle relaxants can increase the risk of urinary incontinence. This, in confluence with a significant rise in the number of individuals who smoke and drink and are suffering from chronic diseases, represents one of the key factors bolstering the market growth. Moreover, urinary incontinence increases due to advancing age. As a result, the growing geriatric population is positively influencing the demand for urinary incontinence devices around the world. Apart from this, the emerging trend of non-invasive treatment options is driving the utilization of at-home devices to treat stress, urge, and bowel incontinence. Furthermore, leading manufacturers are offering innovative products to expand their product portfolio and gain a competitive edge. For instance, Kimberly-Clark Corporation, US-based sanitary products and surgical and medical instruments manufacturing company, launched the Poise Active Collection of ultra-thin pads and liners for women. These thin, absorbent pads and liners instantly absorb and help lock in wetness and odor.
IMARC Group provides an analysis of the key trends in each sub-segment of the global urinary incontinence devices market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, category, incontinence type, patient and end user.
Breakup by Product:
Breakup by Category:
Breakup by Incontinence Type:
Breakup by Patient:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc, Becton Dickinson and Company, Boston Scientific Corporation, Caldera Medical Inc., Coloplast A/S, ConvaTec Group plc, Cook Group Inc., Johnson & Johnson, Kimberly-Clark Corporation, Laborie Medical Technologies Inc., Medtronic plc and Teleflex Incorporated.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Category, Incontinence Type, Patient, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||B. Braun Melsungen AG, Baxter International Inc, Becton Dickinson and Company, Boston Scientific Corporation, Caldera Medical Inc., Coloplast A/S, ConvaTec Group plc, Cook Group Inc., Johnson & Johnson, Kimberly-Clark Corporation, Laborie Medical Technologies Inc., Medtronic plc and Teleflex Incorporated|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
The global urinary incontinence devices market was valued at US$ 2.4 Billion in 2021.
We expect the global urinary incontinence devices market to exhibit a CAGR of 10.77% during 2022-2027.
The high prevalence of neurological diseases, diabetes, obesity, etc., that can increase the risk of urinary incontinence, particularly among the geriatric population, is primarily driving the global urinary incontinence devices market.
The sudden outbreak of the COVID-19 pandemic has led to the rising demand for urinary incontinence devices, such as intermittent catheters, drainage bags, incontinence pads, etc., on account of the high rate of hospital admissions.
Based on the product, the global urinary incontinence devices market can be segmented into urinary catheters, vaginal slings, electrical stimulation devices, artificial urinary sphincters, and others. Currently, vaginal slings hold the majority of the total market share.
Based on the category, the global urinary incontinence devices market has been divided into external urinary incontinence devices and internal urinary incontinence devices, where internal urinary incontinence devices exhibit a clear dominance in the market.
Based on the incontinence type, the global urinary incontinence devices market can be categorized into stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and mixed incontinence. Among these, stress urinary incontinence accounts for the majority of the global market share.
Based on the patient, the global urinary incontinence devices market has been segregated into female and male, where female patients hold the largest market share.
Based on the end user, the global urinary incontinence devices market can be bifurcated into hospitals, ambulatory surgical centers, and others. Currently, hospitals exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global urinary incontinence devices market include B. Braun Melsungen AG, Baxter International Inc, Becton Dickinson and Company, Boston Scientific Corporation, Caldera Medical Inc., Coloplast A/S, ConvaTec Group plc, Cook Group Inc., Johnson & Johnson, Kimberly-Clark Corporation, Laborie Medical Technologies Inc., Medtronic plc, and Teleflex Incorporated.
Hysteroscopes Market by Product (Rigid Hysteroscopes, Flexible Hysteroscopes), Application (Myomectomy, Polypectomy, Endometrial Ablation, and Others), End User(Hospitals, Ambulatory Surgical Centers, Gynecology Clinics, and Others), and Region 2023-2028
Lithotripters Market by Device (Extracorporeal Shock Wave Lithotripsy System, Intracorporeal Lithotripsy System), Application (Kidney Stones, Ureteral Stones, Pancreatic Stones, Bile Duct Stones), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2023-2028
Baby Warming Devices Market by Product (Phototherapy Units, Radiant Warmers, Incubators), Type (Portable, Stand-alone, Convertible), Sales Channel (Online, Offline), End User (Hospitals, Pediatric Centers, Labor and Delivery Centers), and Region 2023-2028
Electrophoresis Equipment Market by Product Type (Gel Electrophoresis Systems, Capillary Electrophoresis Systems, Electrophoresis Accessories), Type (Vertical Electrophoresis, Horizontal Electrophoresis), End User (Hospitals and Diagnostics Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at